WHO 6 months ago
✅ 2025: WHO released its first recommendations on the use of Glucagon-Like Peptide-1 (GLP-1) therapies for treating obesity and weight loss.
WHO recognized 4 countries—Austria, Norway, Oman, and Singapore— for their efforts to eliminate industrial trans fats from food supplies.